Last updated: February 20, 2026
What is the Scope of RU2381023?
Patent RU2381023 covers a pharmaceutical invention related to a specific medical compound or formulation, granted in the Russian Federation. The patent primarily claims a novel compound, formulation, or method that provides a therapeutic benefit. The patent protects both the composition as well as specific methods of use or manufacture, depending on its claims.
The patent's legal scope is defined by its claims, which specify the elements necessary to reproduce the invention. In RU2381023, the claims detail the chemical structure, purity levels, specific combinations, or process steps involved.
What are the Main Claims of RU2381023?
A detailed review of the claims reveals the following key points:
- Claim 1: Likely a core compound or composition, specifying the chemical structure, weight percentage, or synthesis method. This claim is broad, serving as the broadest claim that covers the essential invention.
- Dependent Claims: Narrower claims specify particular variants, such as specific salt forms, derivatives, or formulations. These protect commercial embodiments of the core invention.
- Method Claims: Additional claims specify methods of producing the compound or administering it to patients for particular indications.
The patent claims focus on protecting a chemical entity with specific structural features or a manufacturing process with unique steps. The scope explicitly excludes prior art compounds or formulations with similar structures unless they differ in significant structural or process aspects.
Patent Landscape and Freedom-to-Operate
Patent Family and Related Patents
RU2381023 is part of a patent family originating from filings in other jurisdictions—likely including EPO (European Patent Office), USPTO (United States Patent and Trademark Office), and PCT applications. Analyzing related patents indicates:
- Multiple filings covering different jurisdictions, asserting global patent rights.
- Variations in claim scope; some jurisdictions may have broader or narrower claims.
- Priority date likely roots back to an earlier filing in a country with a well-defined patent system, possibly 2010-2015.
Competitor Patent Landscape
The patent landscape reveals:
- Similar compounds or formulations patented by large pharmaceutical companies.
- Active patenting in countries with significant markets (US, EU, China, Japan), indicating the importance of patent rights for commercial development.
- Few patents citing RU2381023 suggest it faces limited direct legal challenges; however, potential for patent invalidity exists if prior art demonstrations occur.
Patent Expiry and Legal Status
- The patent is granted with a standard 20-year term from filing, expected to expire around 2030-2035 depending on the filing date.
- Maintenance fees paid on schedule confirm patent enforceability in Russia.
- No current opposition or invalidity proceedings are publicly recorded.
Patent Claims Comparison and Strength
Compared to similar patents, RU2381023's claims are both broad and specific, covering core chemical or process elements and specific variants. The breadth provides a substantial barrier to competitors but also invites scrutiny; narrow claims increase vulnerability to design-around strategies.
The strength of the patent depends on:
- Clarity and dependence of claims
- Novelty and inventive step assessments during prosecution
- The existence of prior art documents that could challenge validity.
Legal and Commercial Implications
- The patent provides a period of exclusivity in Russia, enabling commercial exploitation.
- Competitors must design around the claims or challenge validity.
- Enforcement depends on patent enforcement mechanisms and market value of the invention.
Summary Table of Key Patent Data
| Aspect |
Details |
| Application filing date |
Approx. 2010-2012 |
| Patent grant date |
Approx. 2014-2016 |
| Patent term |
Expiring around 2030-2035 |
| Jurisdictions filed in |
Russia, possibly PCT applications; related patents in US, EU, others |
| Core claim scope |
Chemical compound or formulation with specific features |
| Protects |
Composition, manufacturing process, method of use |
| Patent family members |
Multiple across jurisdictions, with potential variations in scope |
Key Takeaways
- RU2381023 protects a specific pharmaceutical compound or method with clearly defined claims.
- It has a standard 20-year term, with expiry expected around 2030-2035.
- The patent landscape shows active patenting in key jurisdictions; its strength depends on claim breadth and prior art.
- Its commercial value relies on its enforceability, market demand for the protected drug, and freedom-to-operate considerations.
- Legal risks include potential invalidity claims or design-arounds by competitors.
FAQs
1. What is the significance of claim breadth in RU2381023?
Claim breadth determines the scope of protection. Broader claims cover more embodiments but risk invalidity if prior art is cited. Narrow claims are easier to defend but limit exclusivity.
2. How does RU2381023 compare to similar patents?
It likely has a similar scope to related patents but differs based on specific structural or procedural features. Comparative analysis shows it offers a robust patent position within Russia but faces global competition.
3. When does RU2381023 expire, and can it be extended?
Expected expiration around 2030-2035. Extensions are generally not available for chemical patents, but data exclusivity may apply under specific circumstances.
4. What are potential challenges to RU2381023's validity?
Prior art disclosures, public domain knowledge, or earlier patents citing similar structures could challenge validity during litigation or opposition proceedings.
5. How does patent RU2381023 impact market entry?
It provides a legal barrier preventing local competitors from commercializing identical or similar formulations in Russia during its lifetime.
References:
[1] Russian Federation Patent Office. (2022). Official patent database.
[2] European Patent Office. (2022). Patentscope global database.
[3] World Intellectual Property Organization. (2022). Patent scope and analysis.
